Release Date: 29/04/19 19:17 Summary: Quarterly Activities and Cash Flow Report - March 2019 Price Sensitive: Yes Download Document 380.42KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status